GRADIENT CAPITAL ADVISORS, LLC Bristol-Myers Squibb Company Transaction History

GRADIENT CAPITAL ADVISORS, LLC portfolio value:

$344,000
portfolio value

Bristol-Myers Squibb Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 4.83K shares 344K $71.09 4.83K